Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Minimal Access vs. Open Spine Surgery in Patients With Metastatic Spinal Cord Compression - A One-Center Randomized Controlled Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term Survival After Surgical Treatment of Spinal Metastasis - The Predictive Role of Sex

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Improving Photoprotection and Implications for 25(OH)D Formation

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Lifetime UVR Dose and Skin Cancer Risk, Determined by Their Common Relation to Solar Lentigines

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Impact of New Motor Deficit on HRQOL after Adult Spinal Deformity Surgery: Subanalysis from Scoli Risk 1 Prospective Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Revision risk after pediatric spinal deformity surgery: a nationwide study with 2-year follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Distraction-to-stall Versus Targeted Distraction in Magnetically Controlled Growing Rods

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND/AIM: We conducted a randomized controlled trial to investigate whether minimally access spine surgery (MASS) is less morbid than open surgery (OS) in patients with metastatic spinal cord compression (MSCC).

PATIENTS AND METHODS: A total of 49 MSCC patients were included in the trial. The outcome measures were bleeding (L), operation time (min), re-operations and prolonged wound healing.

RESULTS: The median age was 67 years (range=42-85 years) and 40% were men. The peri-operative blood loss in the MASS-group was significantly lower than that in the OS-group; 0.175L vs. 0.500L, (p=0.002). The median operation time for MASS was 142 min (range=72-203 min) vs. 103 (range=59-435 min) for OS (p=0.001). There was no significant difference between the two groups concerning revision surgery or delayed wound healing.

CONCLUSION: The MASS technique in MSCC patients is associated with less blood loss, but a longer operation time when compared to the OS technique.

OriginalsprogEngelsk
TidsskriftAnticancer Research
Vol/bind40
Udgave nummer10
Sider (fra-til)5673-5678
Antal sider6
ISSN0250-7005
DOI
StatusUdgivet - okt. 2020

Bibliografisk note

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

ID: 62384985